Delivery Order 75N93021D00003-75N93021F00002

Award Date 6/1/21
Potential Completion Date 9/30/21
Potential Value $17K
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Chapel Hill, NC 27599, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $0 delivery order against the Preclinical Services for HIV Therapeutics master IDIQ contract to the University of North Carolina at Chapel Hill Office of Sponsored Research. The purpose of this task order is to fund the guaranteed minimum amount of the contract to provide preclinical services in support of developing HIV therapeutics. Performance will take...
This delivery order was awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to the University of Nebraska Medical Center under the Preclinical Services for HIV Therapeutics master IDIQ contract. The $13,328.86 order is for the development and delivery of a quality assurance/quality control plan and participation in a task order initiation meeting to support the NIH's work in HIV/AIDS therapeutics research. Performance will take place in Omaha,...
This is a $271,640.00 firm fixed price Delivery Order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to the University of North Carolina at Chapel Hill to perform Task A36 under the NIAID Preclinical Models of Infectious Diseases 2017-2024 indefinite delivery contract. The award has an 18 month period of performance and does not utilize any set-aside designations. The University of North Carolina at Chapel...
This is a delivery order under the National Institute of Allergy and Infectious Diseases (NIAID) Preclinical Models of Infectious Diseases 2017-2024 Indefinite Delivery/Indefinite Quantity (IDIQ) contract. The $3,398,047 award was made to the University of North Carolina at Chapel Hill (UNC-CH), doing business as the Office of Sponsored Research, to provide pre-clinical research services for infectious disease studies. This includes developing and refining animal models to evaluate potential...
This delivery order against the Preclinical Services for HIV Therapeutics master IDIQ contract is valued at $10,535.37 for Rutgers The State University of New Jersey to develop a quality assurance/quality control plan and participate in a task order initiation meeting for the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The work will take place over four months in Newark, New Jersey on a cost-no-fee basis to support the NIH/NIAID's efforts to develop...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to the University of North Carolina at Chapel Hill (UNC-CH) to provide pre-clinical research services for infectious disease studies. The $2,221,849 contract is a Delivery Order under a larger $146.3 million Indefinite Delivery/Indefinite Quantity (IDIQ) contract with UNC-CH that runs through July 2031. The IDIQ supports...
This task order funds the guaranteed minimum amount under the prime contract between Research Triangle Institute (RTI) International and the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The purpose is to support preclinical services for HIV therapeutics research under the larger Preclinical Services for HIV Therapeutics master IDIQ contract vehicle. With a potential value of $0.00, this delivery order was awarded on October 15, 2020 to RTI...
This is a $4,301.88 Firm Fixed Price purchase order awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to the University of North Carolina at Chapel Hill. The order is for Tier 2 analysis by LC-MS/MS of macaque plasma samples to measure the levels of tenofovir (TFV) and emtricitabine (FTC). This work is likely in support of HIV/AIDS research at NIH. UNC-Chapel Hill has received various other prime contract awards from federal agencies for...
Duke University has been awarded a cost-no-fee task order valued at $10.38 million by the National Institutes of Health National Institute of Allergy and Infectious Diseases. The task order was issued against Duke University's existing preclinical and translational vaccine development IDIQ with the agency. Under this task order, Duke University will provide services and materials to support in vitro transcription reactions, mRNA purification, and procurement of lipid raw materials for...
This task order was awarded to Research Triangle Institute, doing business as RTI International, as the prime contractor. RTI will develop and deliver a quality assurance/quality control plan and participate in a task order initiation meeting in support of the Preclinical Services for HIV Therapeutics program, a $17,299 cost-plus-fixed-fee delivery order issued by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The work is being performed under the...

This delivery order against the Preclinical Services for HIV Therapeutics master IDIQ contract with the National Institutes of Health's National Institute of Allergy and Infectious Diseases calls for the University of North Carolina at Chapel Hill Office of Sponsored Research to develop a quality assurance/quality control plan and participate in a task order initiation meeting. Valued at sixteen thousand nine hundred ten dollars and ninety-one cents ($16,910.91), the order has a period of performance from June 1, 2021 through September 30, 2021 and utilizes a cost-no-fee pricing structure. Place of performance will be in Chapel Hill, North Carolina. No subcontractors or set-aside designations are indicated. The National Institute of Allergy and Infectious Diseases supports research on infectious diseases of public health importance such as HIV/AIDS.

Generated 12/31/23, 5:18 AM